10:39 AM EDT, 09/30/2024 (MT Newswires) -- Scorpius Holdings ( SCPX ) said Monday it signed a contract to provide a "publicly traded clinical-stage immuno-oncology company" with bioanalytical services.
Financial terms of the contract were not disclosed.
Shares of Scorpius Holdings ( SCPX ) were up 3.8% in recent trading.
Price: 0.76, Change: +0.03, Percent Change: +3.84